Advertisement

Topics

Kuros Biosurgery AG Company Profile

22:29 EDT 22nd June 2018 | BioPortfolio

Kuros is a biomedical company focused on developing novel injectable materials for localized therapy. The company focuses on three different aspects of localized therapy in which the product goal is to regenerate or restore the function of diseased and damaged tissue or to deliver a therapeutic locally.

Kuros’ objective is to leverage both its proprietary technology for localised therapy and its clinical development and regulatory expertise in order to develop a portfolio of products.

The company is focused on indications of high unmet medical need with initial programs in wounds, surgery, spine and trauma. Kuros will develop and commercialize these innovative products through its own resources and, where commercially appropriate, in partnership and collaboration with other companies.

Kuros is building its portfolio of products by both in-house development and in-licensing. Kuros is flexible in its collaboration/partnering approach and is keen to open discussions in areas of mutual benefit.

Kuros has entered into a strategic collaboration with Baxter to develop products in the fields of hard and soft tissue repair.

Location

Technoparkstrasse 1
Zurich
CH-8005
Switzerland

Contact

Phone: +41 44 200 5600
Fax: +41 44 200 5700
Email: info@kuros.Com


News Articles [16 Associated News Articles listed on BioPortfolio]

Kuros Biosciences Ltd.: Kuros Biosciences weitet Lizenzabkommen mit Checkmate aus

Schlieren (Zürich), Schweiz, 8. Januar 2018 Kuros Biosciences weitet Lizenzabkommen mit Checkmate aus Kuros Biosciences AG (SIX: KURN) gibt die Ausdehnung des exklusiven Lizenzabkommens mit Checkm...

Kuros Biosciences Ltd.: General Meeting of Kuros Biosciences approves all resolutions

Schlieren (Zurich), Switzerland, June 14, 2018 General Meeting of Kuros Biosciences approves all resolutions Kuros announced that today's General Meeting approved all resolutions proposed by the B...

Kuros Biosciences Ltd.: Kuros Biosciences to present promising clinical case studies with MagnetOs at leading spine surgery conference

Schlieren (Zurich), Switzerland, June 19, 2018 Kuros Biosciences to present promising clinical case studies with MagnetOs at leading spine surgery conference Kuros Biosciences will this week prese...

EU approves surgical implants from Aroa Biosurgery

European regulators gave Aroa Biosurgery CE mark approval for its OviTex Reinforced BioScaffold devices, which consist of int -More- 

Kuros weitet Lizenzabkommen mit Checkmate aus

Zürich (awp) - Kuros Biosciences weitet das exklusive Lizenzabkommen mit der US-Firma Checkmate Pharmaceuticals Inc. aus. Im Rahmen des Vertragszusatzes erwirbt Checkmate zusätzliche Rechte am klin....

TRX BioSurgery Receives Supplier Horizon Award from Premier Inc.

TRX BioSurgery, part of the Tissue Regenix Group, today announces that it is a winner of the Supplier Horizon Award from Premier Inc., a leading healthcare improvement comp...

Tissue Regenix says sales in CellRight and BioSurgery divisions started year strongly

"We have completed a transformative acquisition, delivered 46% growth in DermaPure sales and expanded the clinical applications of our products to access new healthcare professionals," said company ch...

Tissue Regenix says sales in CellRight and BioSurgery divisions have had a strong start to the year

"We have completed a transformative acquisition, delivered 46% growth in DermaPure sales and expanded the clinical applications of our products to access new healthcare professionals," said company ch...

Drugs and Medications [1 Associated Drugs and Medications listed on BioPortfolio]

Carticel [Genzyme Corporation]

These highlights do not include all the information needed to use Carticel safely and effectively. See full prescribing information for Carticel. Carticel® (autologous cultured chondrocytes) For Auto...

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

Bilayer Matrix Autologous Chondrocyte Implantation without Bone Graft for Knee Osteochondral Lesion less than 8 mm Deep.

This article investigates the clinical and radiological results of bilayer matrix autologous chondrocyte implantation (MACI) membrane technique in the treatment of shallow osteochondral defects. An an...

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

A Study to Compare Subject Comfort During and After Injections With the Study Products and the Safety of the Non-FDA Approved Product for the Correction of Nasolabial Folds (NLFs)

The purpose of this research study is to compare subject comfort during and after injection with NADGL and Captique® Injectable Gel, in the nasolabial folds. Captique® is an FDA-approve...

A Study to Compare the Safety and Effectiveness of a Non-FDA Approved Device (DGE) and an FDA Approved Device for the Correction of Nasolabial Folds (NLFs)

The purpose of this research study is to evaluate the safety and effectiveness of injection with DGE Injectable Gel (manufactured by Genzyme Biosurgery) as compared to injection with a Foo...

Companies [9 Associated Companies listed on BioPortfolio]

Kuros Biosurgery AG

Kuros is a biomedical company focused on developing novel injectable materials for localized therapy. The company focuses on three different aspects of localized therapy in which the product goal is t...

Aroa Biosurgery Ltd

Aroa Biosurgery (Aroa) is a privately held soft tissue repair and reconstruction company.

BioMonde, LLC

Since 1994 BioMonde have manufactured and supplied Larval Therapy in Europe and the UK. BioMonde are the sole producers of ‘BioBag,’ which provides clinicians and patien...

Orthovita, Inc.

Orthovita, Inc. is a specialty spine and orthopedic company with a portfolio of orthobiologic and biosurgery products. Our products are based on novel and unique proprietary bioma...

Organogenesis

Having pioneered the field, Massachusetts based Organogenesis, Inc. is a leading regenerative medicine company focused in the areas of bioactive wound healing, oral regeneration and biosurgery. The co...

More Information about "Kuros Biosurgery AG" on BioPortfolio

We have published hundreds of Kuros Biosurgery AG news stories on BioPortfolio along with dozens of Kuros Biosurgery AG Clinical Trials and PubMed Articles about Kuros Biosurgery AG for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Kuros Biosurgery AG Companies in our database. You can also find out about relevant Kuros Biosurgery AG Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record